Inventor · disambiguated record
Robert Scannevin
Also filed as: SCANNEVIN ROBERT · SCANNEVIN ROBERT H · SCANNEVIN ROBERT HUGHIE
9 granted patents·9 pending applications·16 citations·filing 2007–2025
82Inventor score
Files withJANSSEN PHARMACEUTICA NV5YUMANITY THERAPEUTICS INC4LEONARD KRISTI A3BIOGEN MA INC2JACKSON PAUL FRANCIS1
Top patents by PatentIndex Score
18 records- 0192US12275723B2Compounds and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2023·Granted Apr 15, 2025·1 cites·16 claims
- 0291US10973810B2Methods for the treatment of neurological disordersYUMANITY THERAPEUTICS INC·Filed 2018·Granted Apr 13, 2021·7 cites·10 claims
- 0386US12433880B2Methods for the treatment of neurological disordersJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Oct 7, 2025·1 cites·23 claims
- 0479US11873298B2Compounds and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Jan 16, 2024·1 cites·8 claims
- 0579US7803793B2Heterocyclic derived metalloprotease inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Sep 28, 2010·5 cites·32 claims
- 0677US2025304569A1Compounds and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2025·Application pending·0 cites
- 0763US11241417B2Compositions and methods for the treatment and prevention of neurological disordersYUMANITY THERAPEUTICS INC·Filed 2019·Granted Feb 8, 2022·0 cites·8 claims
- 0863US8883473B2Methods of treatment using allosteric processing inhibitors for matrix metalloproteinasesLEONARD KRISTI A·Filed 2012·Granted Nov 11, 2014·1 cites·14 claims
- 0963US2022110920A1Compositions and methods for the treatment and prevention of neurological disordersYUMANITY THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1053US2024016810A1Compositions and methods for the treatment and prevention of neurological disordersKINETA INC·Filed 2021·Application pending·0 cites
- 1150US8798939B2Methods for designing, selecting and/or optimizing allosteric processing inhibitors for matrix metalloproteinasesLEONARD KRISTI A·Filed 2012·Granted Aug 5, 2014·0 cites·4 claims
- 1247US2020222400A1Methods for the treatment of neurological disordersYUMANITY THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1345US2008085893A1Matrix metalloprotease inhibitorsYANG SHYH-MING·Filed 2007·Application pending·0 cites
- 1445US2016115540A1Prodrugs and drugsBIOGEN MA INC·Filed 2014·Application pending·0 cites
- 1538US8753857B2Crystal structure of the pro form of a matrix metalloproteinase and an allosteric processing inhibitorLEONARD KRISTI A·Filed 2012·Granted Jun 17, 2014·0 cites·4 claims
- 1638US2012302573A1Methods of inhibiting pro matrix metalloproteinase activationJACKSON PAUL FRANCIS·Filed 2012·Application pending·0 cites
- 1734US2018289655A1Methods and Compositions for the Intravenous Administration of Fumarates for the Treatment of Neurological DiseasesBIOGEN MA INC·Filed 2016·Application pending·0 cites
- 1834US2010279986A1Heterocyclic derived metalloprotease inhibitorsZHANG YUE-MEI·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert Scannevin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →